Sign up to save your podcasts
Or
Share Emerging data with immunotherapy in ESCC and potential impact for clinical practice
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Emerging data with immunotherapy in ESCC and potential impact for clinical practice
touchTALKS for touchONCOLOLOGY
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert:
- Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
Overview:
Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023
View all episodes
By touchpodcasttouchTALKS for touchONCOLOLOGY
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert:
- Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
Overview:
Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023